Literature DB >> 12468292

Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model.

Trachette L Jackson1.   

Abstract

A spatio-temporal model of tumor response to sequestered, intracellular doxorubicin is presented and simulated. An important feature of the model is the characterization of different mechanisms by which doxorubicin initiates the cell death cascade. The model predicts that the long-term response of the tumor to repeated rounds of therapy is very sensitive to changes in the threshold level of doxorubicin required to initiate apoptosis at the maximum rate. In fact, perturbations of this parameter mediate the difference between effective tumor regression and minimal growth delays. The model is also used to investigate which parameters are most influential in rendering the tumor drug resistant. Sensitivity analysis shows that decreasing cellular permeability, as opposed to decreasing sequestration rate or increasing cellular efflux, is the most effective way for tumor cells to overcome the growth control afforded by successive rounds of treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12468292     DOI: 10.1006/jtbi.2003.3156

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  26 in total

1.  Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ari Partanen; Pavel S Yarmolenko; David Woods; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ayele Negussie; Bradford J Wood; Frank Rattay; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

3.  Spatio-temporal tumour model for analysis and mechanism of action of intracellular drug accumulation.

Authors:  Somna Mishra; V K Katiyar
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

4.  The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems.

Authors:  Min Wu; Hermann B Frieboes; Mark A J Chaplain; Steven R McDougall; Vittorio Cristini; John S Lowengrub
Journal:  J Theor Biol       Date:  2014-04-19       Impact factor: 2.691

5.  P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model.

Authors:  Kenneth T Luu; James A Uchizono
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

6.  A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.

Authors:  Steffen Eikenberry
Journal:  Theor Biol Med Model       Date:  2009-08-09       Impact factor: 2.432

7.  Oscillatory dynamics in a model of vascular tumour growth--implications for chemotherapy.

Authors:  I J Stamper; M R Owen; P K Maini; H M Byrne
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

8.  Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.

Authors:  John P Sinek; Sandeep Sanga; Xiaoming Zheng; Hermann B Frieboes; Mauro Ferrari; Vittorio Cristini
Journal:  J Math Biol       Date:  2008-09-10       Impact factor: 2.259

9.  Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies.

Authors:  Raja Venkatasubramanian; Michael A Henson; Neil S Forbes
Journal:  J Theor Biol       Date:  2008-02-21       Impact factor: 2.691

10.  The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.

Authors:  Krupa J Patel; Ian F Tannock
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.